Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-064529
Filing Date
2025-05-06
Accepted
2025-05-06 16:30:33
Documents
60
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cytk-20250331.htm   iXBRL 10-Q 2269840
2 EX-31.1 cytk-ex31_1.htm EX-31.1 17141
3 EX-31.2 cytk-ex31_2.htm EX-31.2 17190
4 EX-32.1 cytk-ex32_1.htm EX-32.1 10446
  Complete submission text file 0000950170-25-064529.txt   9041479

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT cytk-20250331.xsd EX-101.SCH 1436449
62 EXTRACTED XBRL INSTANCE DOCUMENT cytk-20250331_htm.xml XML 1373494
Mailing Address 350 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 350 OYSTER POINT BOULEVARD . SOUTH SAN FRANCISCO CA 94080 (650) 624-3000
CYTOKINETICS INC (Filer) CIK: 0001061983 (see all company filings)

EIN.: 943291317 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50633 | Film No.: 25917743
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)